StockpollyBeta
Get App
Delisting riskPopularity #3,749
LUCD · NASDAQ · Medical - Devices

Lucid Diagnostics (LUCD)

Commercializes EsoGuard testing on esophageal cells collected with EsoCheck.

$0.8926
After hours+0.01 (+1.00%)
At close$0.8838(+4.58%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue111111111211
Cost of revenue212222222221
Gross profit−10−1−1−1−1−1−100−10
101110111111121111141213
Research & development222121111211
8989910109,624101210,43412
Selling & marketing44444444,007455,0026
General & administrative44455665,617665,4326
Other expenses1100000−9,61400−10,4240
Operating income−11−11−11−11−12−12−12−11−12−14−12−13
−3100−11−1471−2−21
Interest income000000000000
Interest expense000000000000
Other non-operating income3−1001−114−7−122−1
Income before tax−14−11−11−11−12−12−27−4−10−16−14−12
Net income from continuing operations−14−11−11−11−12−12−27−4−10−16−14−12
Net income−14−11−11−11−12−12−27−4−10−16−14−12
EPS, basic−$0.34−$0.26−$0.40−$0.23−$0.25−$0.20−$0.52−$0.08−$0.10−$0.12−$0.17−$0.08
EPS, diluted−$0.34−$0.26−$0.40−$0.23−$0.25−$0.20−$0.52−$0.08−$0.10−$0.12−$0.17−$0.08
Weighted average shares, basic4242454850586999108102102183
Weighted average shares, diluted4242454850586999108102102183
EBITDA−13−10−10−11−12−11−27−4−10−16−14−11
Depreciation & amortization111000000000
EBIT−14−11−11−11−12−12−27−4−10−16−14−12